Articles

And the sheep shall lead them...

Day-blind sheep bring potential relief for human eye conditions into focus
Written byKristen Smith
| 3 min read

JERUSALEM—It started with a call from a concerned Israeli farmer. Beginning in 2003, the shepherd had noticed some sheep in his flock displaying signs of day blindness. Over the next five years, the prevalence in the herd grew—until he finally reached out to Dr. Ron Ofri, an associate professor of veterinary ophthalmology at Hebrew University of Jerusalem. Upon examination, Ofri determined the sheep all suffered from CNGA3 achromatopsia, a genetic mutation causing affected animals to experience blindness during the day and limited vision at night.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
3D illustration of a multicolored protein structure composed of folded ribbon-like strands against a blue and teal background with scattered spherical particles
Learn how advanced analytical methods support the characterization of antibody–C1q interactions and the qualification of analytical binding assays.